Fundraising FoxVensana Capital — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Elucent develops precision-guided surgical technologies that use 3D spatial positioning to make surgical procedures less invasive and more effective.
Deep TechHardwareHealthtechMedical Devices
Jason Pesterfield(President & Chief Executive Officer)in
Co-investorsRC CapitalAvestria VenturesBaird Capital
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Founder)
BoardLee Cooper(Director)Scott Barclay(Director)inLouis Samson(Director)
Board seatPeter Justin Klein· per SEC Form D
Co-investorsBattery VenturesBreyer CapitalCatalytic Impact FoundationDigiTx Partners LLCEsplanade VenturesInsight Partners+6 more
IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.
Deep TechHealthtechMedical DevicesRoseville, US
Todd Kerkow(Co-Founder, President and CEO)inMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)
Board seatAmrinder SinghKirk Nielsen· per SEC Form D
Co-investorsHatteras Venture PartnersTreo Ventures, Llc
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.